PLK2 Antibody

說明書

中文名稱：

PLK2兔多克隆抗體
貨號：

CSB-PA745425
規格：

￥1090
圖片：
Immunohistochemical analysis of paraffin-embedded human-kidney, antibody was diluted at 1:200
其他：

產品詳情
產品評價
相關產品
靶點詳情

產品詳情

Uniprot No.：

Q9NYY3
基因名：

PLK2
別名：

hPlk2 antibody; hSNK antibody; PLK-2 antibody; Plk2 antibody; PLK2_HUMAN antibody; Polo like kinase 2 antibody; Polo-like kinase 2 antibody; Serine/threonine protein kinase PLK2 antibody; Serine/threonine protein kinase SNK antibody; Serine/threonine-protein kinase PLK2 antibody; Serine/threonine-protein kinase SNK antibody; Serum Induced Kinase antibody; Serum-inducible kinase antibody; SNK antibody
宿主：

Rabbit
反應種屬：

Human,Rat
免疫原：

Synthetic peptide from Human protein at AA range: 1268-1341
免疫原種屬：

Homo sapiens (Human)
標記方式：

Non-conjugated
純化方式：

The antibody was affinity-purified from rabbit serum by affinity-chromatography using specific immunogen.
濃度：

It differs from different batches. Please contact us to confirm it.
保存緩沖液：

Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide.
產品提供形式：

Liquid
應用范圍：

IHC,ELISA

推薦稀釋比：

Application	Recommended Dilution
IHC	IHC-p:1:50-1:300
ELISA	1:5000-1:20000

Protocols：

Immunohistochemistry (IHC) Protocol
ELISA Protocol
儲存條件：

Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
貨期：

Basically, we can dispatch the products out in 1-3 working days after receiving your orders. Delivery time maybe differs from different purchasing way or location, please kindly consult your local distributors for specific delivery time.
用途：

For Research Use Only. Not for use in diagnostic or therapeutic procedures.

產品評價

靶點詳情

功能：

Tumor suppressor serine/threonine-protein kinase involved in synaptic plasticity, centriole duplication and G1/S phase transition. Polo-like kinases act by binding and phosphorylating proteins are that already phosphorylated on a specific motif recognized by the POLO box domains. Phosphorylates CENPJ, NPM1, RAPGEF2, RASGRF1, SNCA, SIPA1L1 and SYNGAP1. Plays a key role in synaptic plasticity and memory by regulating the Ras and Rap protein signaling: required for overactivity-dependent spine remodeling by phosphorylating the Ras activator RASGRF1 and the Rap inhibitor SIPA1L1 leading to their degradation by the proteasome. Conversely, phosphorylates the Rap activator RAPGEF2 and the Ras inhibitor SYNGAP1, promoting their activity. Also regulates synaptic plasticity independently of kinase activity, via its interaction with NSF that disrupts the interaction between NSF and the GRIA2 subunit of AMPARs, leading to a rapid rundown of AMPAR-mediated current that occludes long term depression. Required for procentriole formation and centriole duplication by phosphorylating CENPJ and NPM1, respectively. Its induction by p53/TP53 suggests that it may participate in the mitotic checkpoint following stress.
基因功能參考文獻：
1. The p53 dependence of Plk2 loss and tumor suppressor function in relationship to mTOR signaling may have therapeutic implications. PMID: 29448085
2. FOXD1 promoted the expression of Plk2 mRNA and protein in colorectal cancer cells. PMID: 29864920
3. we discovered that PLK2 might be inactivated in microsatellite-instability high colorectal cancers, suggesting that PLK2 could be a tumor-suppressing gene in these cancers. PMID: 28698103
4. study demonstrates that PLK-2 activity can rapidly change cellular alpha-synuclein levels in cell models and in mice brains, but this process does not require phosphorylation of S129. Instead, it operates via regulation of alpha-synuclein mRNA transcription in an open reading frame-dependent manner PMID: 28648742
5. Findings indicate the interaction network of viral oncogene HPV16 E7, miR-27b and PLK2, and support the potential strategies using antisense nucleic acid of miR-27b for therapy of cervical cancer. PMID: 26910911
6. CHOP negatively regulates Polo-like kinase 2 expression via recruiting C/EBPalpha to the upstream-promoter in human osteosarcoma cell line during ER stress PMID: 28652211
7. Plk2 represents an independent prognostic marker and regulates tumor growth and apoptosis by targeting Fbxw7/Cyclin E pathway in colorectal carcinoma. PMID: 27423313
8. PLK2 kinase has a role in mediating alpha-synuclein selective autophagic degradation PMID: 28154193
9. PLK2, functional kinase and polo-box domains were required for interaction with PFV Gag. Fluorescently-tagged PFV Gag, through its chromatin tethering function, selectively relocalized ectopically expressed eGFP-tagged PLK proteins to mitotic chromosomes i PMID: 27579920
10. Develop a DDS for continuous intracellular delivery of PLK2. PMID: 27863657
11. Structural analysis of the polo-box domain of human PLK2 has been presented. PMID: 25846005
12. our study demonstrates a novel mechanism of PLK2 in promoting tumor progression, whereby it directly binds to enriched TAp73, catalyzes Ser48 phosphorylation of TAp73, and inhibits TAp73 transcriptional activity PMID: 26625870
13. Data suggest wild-type SNCA (alpha-synuclein) binding to synaptosome membrane is not affected by phosphorylation by PLK2; A30P SNCA, a Parkinson disease mutation, binding is greatly increased; endocytosis of SNCA fibrils follows similar pattern. PMID: 26719332
14. Decreased PLK2 protein expression due to promoter hypermethylation was negatively correlated with JAK2 overexpression, a common occurrence in hematological malignancies. PMID: 25347426
15. PLK2 SNPs were associated with Alzheimer disease and mild cognitive impairment. PLK2-rs15009 CC and GG genotypes and CC genotype at PLK2-rs702723 were protective for AD. PMID: 24384746
16. PLK2 indirectly activates ROCK2 via phosphorylating nucleophosmin during centrosome amplification. PMID: 25590559
17. these findings reveal a conserved PLK2-RAP1 pathway that is crucial to regulate endothelial tip cell behavior in order to ensure proper vascular development and patterning in vertebrates. PMID: 26004360
18. Silencing of polo-like kinase 2 increases cell proliferation and decreases apoptosis in SGC-7901 gastric cancer cells. PMID: 25501818
19. Unique PLK2-dependent protein phosphorylation sites identified by mass spectrometry. PMID: 25338102
20. the regulation of redox homeostasis by PLK2 promotes the survival of cells with dysfunctional mitochondria PMID: 24887096
21. Data shows that PLK2 mRNA is a direct target of miR-27a in laryngeal squamous cell carcinoma. PMID: 25239093
22. this study reports the first crystal structure of the C-terminal polo-box domain of PLK2. PMID: 25511705
23. Study indicates that miR-126 is a tumor suppressor that inhibits gastric cancer cells proliferation by targeting PI3KR2, Crk and PLK2. PMID: 24969300
24. This study supports a role for PLK2 in the generation of aSyn inclusions by a mechanism that does not depend directly on serine 129 phosphorylation. PMID: 23677647
25. Our findings suggest a new role for PLK2 in the regulation of inflammatory diseases by modulating ADAM17 activity. PMID: 24338472
26. Polo-like kinase 2 is a mediator of hedgehog survival signaling in cholangiocarcinoma. PMID: 23703673
27. PLK2 inhibition is a tractable CNS pharmacological target that does not cause genotoxicity at doses and exposures that engage the target in the sensory retina. PMID: 23466428
28. Phosphorylation of Fbxw7 by Plk2 induces destabilization of the F-box protein resulting in accumulation of cyclin E and increased potential for centriole reproduction PMID: 22399798
29. have identified and validated as in vitro PLK2 and PLK3 substrates HSP90, GRP-94, beta-tubulin, calumenin, and 14-3-3 epsilon PMID: 22828320
30. Mutant p53 oncogenic functions are sustained by Plk2 kinase through an autoregulatory feedback loop. PMID: 22134238
31. The methylation status of the PLK2 CpG island predicts outcomes in patients treated with carboplatin and paclitaxel chemotherapy. PMID: 22289679
32. phosphorylation sites could play an important role in the rapid activation, expansion, and prolongation of Plk2 signaling PMID: 22100274
33. PLK2 and to a lesser extent PLK3 are superior over CK2, as catalysts of Ser-129 phosphorylation both in full length alpha-synuclein and in a peptide reproducing the C-terminal segment of the protein. PMID: 22248692
34. Acetylation of GATA-1 responsive elements in Polo-like kinase 2 plays a crucial role in Plk2 transcription and protein expression in MG-63 cells. PMID: 22138223
35. Polo-like kinase 2 (SNK/PLK2) is a novel epigenetically regulated gene in acute myeloid leukemia and myelodysplastic syndromes. PMID: 21340720
36. Results implicate Plk2 as a clinically important determinant of chemosensitivity. PMID: 21402713
37. Identification of Snk/Plk2 as a novel methylated gene in multiple myeloma. PMID: 21067440
38. NPM/B23 is a direct target of Plk2 in the regulation of centriole duplication and that phosphorylation on serine 4 can trigger this process PMID: 20352051
39. Results identify centrosomal P4.1-associated protein (CPAP), a human homologue of SAS-4, as a substrate of PLK2 whose activity oscillates during the cell cycle. PMID: 20531387
40. overexpression of PLK2 in bladder carcinomas, suggesting a possible role of PLK2 in the pathogenesis of bladder carcinomas PMID: 19506885
41. Our results point to a novel Plk2-TSC1 interaction with effects on mTOR signaling during hypoxia, and tumor growth that may enable targeting Plk2 signaling in cancer therapy. PMID: 20054236
42. there is a mitotic checkpoint wherein p53-dependent activation of Snk/Plk2 prevents mitotic catastrophe following spindle damage PMID: 12897130
43. hVPS18 may play an important role in regulation of SNK activity through its ubiquitin ligase PMID: 16203730
44. Calcipotriol affects proliferation of keratinocytes by decreasing the expression of EGR1 and PLK2 PMID: 17671831
45. is a novel target of ERRgamma, and their interaction is crucial for cancer cell proliferation PMID: 17706602
46. increased cell death observed after aphidicolin treatment and release in Plk2-deficient cells may result from both higher levels of replication stress-induced DNA damage and a dysfunctional S-phase checkpoint PMID: 17912033
47. PLK2 directly phosphorylates alpha-synuclein at Ser-129 in an in vitro biochemical assay PMID: 19004816
48. Data show that PLK2 as a kinase that phosphorylates Ser-137 of PLK1, which is sufficient to mediate this survival signal. PMID: 19706541
顯示更多

收起更多
亞細胞定位：

Cytoplasm, cytoskeleton, microtubule organizing center, centrosome, centriole. Cell projection, dendrite. Note=Localizes to centrosomes during early G1 phase where it only associates to the mother centriole and then distributes equally to both mother and daughter centrioles at the onset of S phase.
蛋白家族：

Protein kinase superfamily, Ser/Thr protein kinase family, CDC5/Polo subfamily
組織特異性：

Expressed at higher level in the fetal lung, kidney, spleen and heart.
數據庫鏈接：

HGNC: 19699

OMIM: 607023

KEGG: hsa:10769

STRING: 9606.ENSP00000274289

UniGene: Hs.398157

Most popular with customers

YWHAG Recombinant Monoclonal Antibody

Applications: ELISA, WB, IHC

Species Reactivity: Human
YWHAB Recombinant Monoclonal Antibody

Applications: ELISA, WB, IHC, IF, FC

Species Reactivity: Human, Mouse, Rat
Phospho-YAP1 (S127) Recombinant Monoclonal Antibody

Applications: ELISA, WB, IHC

Species Reactivity: Human
XRCC5 Recombinant Monoclonal Antibody

Applications: ELISA, WB, IHC, IF

Species Reactivity: Human
XPNPEP1 Recombinant Monoclonal Antibody

Applications: ELISA, IHC, FC

Species Reactivity: Human
XDH Recombinant Monoclonal Antibody

Applications: ELISA, WB, IHC

Species Reactivity: Human
WT1 Recombinant Monoclonal Antibody

Applications: ELISA, WB, IHC

Species Reactivity: Human
WFDC2 Recombinant Monoclonal Antibody

Applications: ELISA, WB, FC

Species Reactivity: Human